Topic: Acne

News | October 21, 2019

FDA Approves Amzeeq Minocycline Foam from Foamix

The FDA has approved Amzeeq (minocycline) topical foam, 4%, from Foamix Pharmaceuticals for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in adults and pediatric patients 9 years of age and older....

News | October 18, 2019

Foamix Update: Nine Trials in Five Posters

Results from nine clinical trials of Foamix Pharmaceutical investigational products will be presented in five posters at the 39th Annual Fall Clinical Dermatology Conferencein Las Vegas. Findings relate FMX101 for the treatment of...

News | October 15, 2019

Altreno: Exclusive Size Available for Dermatologist Dispensing

Altreno (tretinoin) Lotion, 0.05%, is now available exclusively for physician dispensing in a 20-gram size. Launched last year, Altreno Lotion from Ortho Dermatologics is the first and only tretinoin available in a lotion for...

DermWireTV: Latest on Galderma, Eczema Awareness, Hacking Derm, and More

Series: DermWire TV | October 10, 2019

In this week’s edition: Galderma’s Aklief (trifarotene) topical cream is now approved for acne. Sandra Johnson, MD weighs in. Supported by Sanofi and Regeneron in partnership with the National Eczema Association, the Understand AD Squad includes dermatologist Mercedes Gonzalez, MD, who discusses her experience. Sandy Klein, co-trustee of the Lynn Waxman Foundation, is this year’s Skin Cancer Foundation Champions for Change Honoree. The Hacking Dermatology 2019 Hackathon puts innovation front and center.

Watch Video

News | September 11, 2019

Aczone 7.5% Gel Now Approved Down to Age 9

The FDA has approved the expanded indication for Almirall’s Aczone® 7.5% Gel to include patients aged 9-11. Aczone 7.5% Gel was previously approved in February 2016 to treat inflammatory and non-inflammatory acne in patients 12...